DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a

DaVita Inc. (DVA) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, DaVita Inc. (DVA) trades at a EV/EBITDA of 7.8×. Over the past ten years it has ranged from 5.6× (August 2017) to 13.1× (May 2015); the current reading is higher than 40% of that period. That is below the Medical Care Facilities industry median of 10.2× and below the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 6.6× (12.90%)
FY2024 7.5× 0.52%
FY2023 7.5× 0.50%
FY2022 7.5× (8.87%)
FY2021 8.2× (11.92%)
FY2020 9.3× 14.29%
FY2019 8.1× (6.73%)
FY2018 8.7× 0.61%
FY2017 8.7× 12.26%
FY2016 7.7× (37.65%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 8.6× 18.91%
Mar 2026 7.2× 10.35%
Dec 2025 6.6× (5.16%)
Sep 2025 6.9× (5.07%)
42 more quarters

Against its own ten years

Low 5.6× High 13.1×
Ten-year median 8.1×
Current reading's percentile 40

EV/EBITDA against peers

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on DVA